Abstract:Embryo quality ranks one of the most important predictors in determining the success of implantation, and, clinically, some patients experience repeated IVF failure because of refractory poor embryo quality due to poor oocyte quality. Researches over the past decades leave no doubt that mitochondria are a hallmark of quality and developmental potential of human oocytes, therefore, mitochondrial transfer (MIT), i.e, injecting mitochondria into oocyte, was proposed to improve oocyte quality. Recent studies showed that mitochondrial transfer of mesenchymal stem cells (MSC) effectively protects epithelial cells from mitochondrial damage, suggesting mitochondria in MSC is healthy enough to be good sources for MIT treatment. Therefore, the aim of this study is to investigate the effect of MIT from autologous MSC in improving oocyte quality and clinical outcome in an IVF/ICSI program. Patients with repeated IVF/ICSI failure due to refractory poor embryo quality (no good-quality embryos obtained in at least two previous IVF cycles) were recruited in this retrospective study. 52 patients were recruited in this study. Prior to ovarian stimulation, 20 ml of bone marrow were aspirated from each patient’s iliac crest under local anesthesia and BMSCs were isolated, cultured and frozen in vitro, and then thawed two days before oocyte retrieval for mitochondria preparation through differential centrifuge. Fluorescent real-time PCR was applied to quantify the absolute copy number of mtDNA. All mitochondria were suspended in fertilization medium for injection and 2 pl of solution (approximately 4000-5000 copy number of mtDNA) were injected into each mature oocyte together with one sperm during ICSI procedure. The average age and number of previous failed IVF cycles of this group of patients were 37.69±5.96 y and 4.75± 2.10 respectively. The mean number of oocytes obtained, mature oocytes, 2PNs, transferrable embryos and good-quality embryos were 8.04±5.41, 6.06±4.23, 4.54±3.46, 2.21±2.19 and 1.48±1.84, respectively. One in three D3 embryos was graded as good-quality after MIT, the rate of good-quality embryo was significantly higher than that in previous cycles (33.17% vs. 0%, P<0.05). Fresh embryo transfer was performed in 19 patients, and the pregnancy rate was 31.58% (6/19). In 18 patients, fresh embryo transfer was cancelled and the mean number of embryos frozen was 1.61±1.20. In summary, transferring mitochondria from autologous BMSCs into oocytes offer a new potential treatment to rescue compromised oocytes and normalizes embryo development without disturbing patients’ mtDNA fingerprint.

Mitochondria: the panacea to improve oocyte quality?

Mitochondrial Functions on Oocytes and Preimplantation Embryos

Mitochondria: emerging therapeutic strategies for oocyte rescue

Oocyte mitochondria—key regulators of oocyte function and potential therapeutic targets for improving fertility

Research progress on mitochondrial damage and repairing in oocytes: a review

Research progresses in the functions of oocyte mitochondria

Improving oocyte quality by transfer of autologous mitochondria from fully grown oocytes

Targeting Mitochondria for Ovarian Aging: New Insights into Mechanisms and Therapeutic Potential

Advances in role of mitochondria in maturation of oocyte

The Role of Mitochondria in Oocyte Maturation

Mitochondrial Transfer from Autologous Bone Marrow Mesenchymal Stem Cells Improves Oocyte Quality

Effect of Mitophagy in Oocytes and Granulosa Cells on Oocyte Quality†

Oocyte Health and Quality: Implication of Mitochondria-related Organelle Interactions

Spatiotemporal Distribution and Function of Mitochondria in Oocytes

Oocyte Mitochondiral Aging——Bottleneck of Assisted Reproductive Technology(ART)

Mitochondrial Quality Control in Ovarian Function: From Mechanisms to Therapeutic Strategies

Transfer of autologous mitochondria from adipose tissue-derived stem cells rescues oocyte quality and infertility in aged mice

Mechanisms of mitochondrial dysfunction in ovarian aging and potential interventions

Mitochondrial Transfer from Aged Adipose-Derived Stem Cells Does Not Improve the Quality of Aged Oocytes in C57BL/6 Mice

Mitochondria as therapeutic targets in assisted reproduction

Mitochondrial Transfer from Induced Pluripotent Stem Cells Rescues Developmental Potential of in Vitro Fertilized Embryos from Aging Females†.